Browse EV MemProt Atlas
- Frequency:
- literature support frequency.
- EVMP score:
annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| T4S18 | Q96CE8 | Transmembrane 4 L6 family member 18 | Predicted membrane proteinsTransporters | 4 | Other mediation | 1 | 0.50 | |||
| T4S20 | Q53R12 | Transmembrane 4 L6 family member 20 | Disease related genesPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters | 4 | Adhesion and uptake mediation | 1 | 0.50 | |||
| T4S4 | P48230 | Transmembrane 4 L6 family member 4 (Intestine and liver tetraspan membrane protein) (IL-TMP) | Predicted membrane proteinsTransporters | 4 | Other mediation | 1 | 0.50 | |||
| T4S5 | O14894 | Transmembrane 4 L6 family member 5 (Tetraspan transmembrane protein L6H) | 4 | Fusion and delivery mediation | 1 | 0.50 | ||||
| TA2R | P21731 | Thromboxane A2 receptor (TXA2-R) (Prostanoid TP receptor) | 7 | Angina pectorisArterial occlusive diseaseAsthmaCardiovascular diseaseChronic arterial occlusive diseaseCoronary atherosclerosisDiabetic foot ulcerMyocardial infarctionNeuropathySexual dysfunctionSolid tumour/cancerThrombosisVasomotor/allergic rhinitis | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | |||
| TBC24 | Q9ULP9 | TBC1 domain family member 24 | Disease related genesHuman disease related genesPredicted intracellular proteinsPredicted membrane proteins | Fusion and delivery mediation | 1 | 0.50 | ||||
| TCAF2 | A6NFQ2 | TRPM8 channel-associated factor 2 (TRP channel-associated factor 2) | Predicted intracellular proteins | Fusion and delivery mediation | 1 | 0.50 | ||||
| TEN1 | Q9UKZ4 | Teneurin-1 (Ten-1) (Protein Odd Oz/ten-m homolog 1) (Tenascin-M1) (Ten-m1) (Teneurin transmembrane protein 1) [Cleaved into: Ten-1 intracellular domain (IDten-1) (Ten-1 ICD); Teneurin C-terminal-associated peptide (TCPA-1) (Ten-1 extracellular domain) (Ten-1 ECD)] | Predicted membrane proteinsTransporters | 1 | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | |||
| TGFR1 | P36897 | TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) | Disease related genesEnzymesHuman disease related genesPotential drug targetsPredicted intracellular proteinsPredicted membrane proteins | 1 | Arterial occlusive diseaseBrain cancerCachexiaFibrosisIdiopathic interstitial pneumonitisLiver cancerLung cancerMyelodysplastic syndromeMyeloproliferative neoplasmPancreatic cancerPulmonary diseaseSolid tumour/cancerSystemic sclerosisUreteral cancer | Clinical-translation mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||
| TGFR2 | P37173 | TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II) | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | |||
| TIE2 | Q02763 | Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) | Cancer-related genesCD markersDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPlasma proteinsPredicted membrane proteinsPredicted secreted proteinsRAS pathway related proteins | 1 | Breast cancerChronic arterial occlusive diseaseIschemiaMature B-cell lymphomaMyelodysplastic syndromeMyeloproliferative neoplasmRetinopathyRheumatoid arthritisSepsisSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | ||
| TIKI2 | A6NFA1 | Metalloprotease TIKI2 (EC 3.4.-.-) (Heart, kidney and adipose-enriched transmembrane protein homolog) (TRAB domain-containing protein 2B) | Predicted intracellular proteins | 1 | Receptor-signaling mediation | 1 | 0.50 | |||
| TLR10 | Q9BXR5 | Toll-like receptor 10 (CD antigen CD290) | 1 | Clinical-translation mediationImmune mediation | 1 | 0.50 | ||||
| TLR2 | O60603 | Toll-like receptor 2 (Toll/interleukin-1 receptor-like protein 4) (CD antigen CD282) | 1 | Diabetes mellitusMelanomaMyelodysplastic syndromePancreatic cancerProstate cancerRadiation effectSolid tumour/cancerCOVID-19 | Clinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | |||
| TM222 | Q9H0R3 | Transmembrane protein 222 | Disease related genesHuman disease related genesPredicted membrane proteins | 3 | Other mediation | 1 | 0.50 | |||
| TM237 | Q96Q45 | Transmembrane protein 237 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein) | Disease related genesHuman disease related genesPotential drug targetsPredicted membrane proteinsTransporters | 4 | Receptor-signaling mediation | 1 | 0.50 | |||
| TM245 | Q9H330 | Transmembrane protein 245 (Protein CG-2) | Predicted membrane proteinsTransporters | 14 | Other mediation | 1 | 0.50 | |||
| TM266 | Q2M3C6 | Transmembrane protein 266 (hTMEM266) (HV1-related protein 1) (HsHVRP1) | Predicted membrane proteins | 4 | Other mediation | 1 | 0.50 | |||
| TMG1 | O14668 | Transmembrane gamma-carboxyglutamic acid protein 1 (Proline-rich gamma-carboxyglutamic acid protein 1) (Proline-rich Gla protein 1) | 1 | Immune mediation | 1 | 0.50 | ||||
| TMM52 | Q8NDY8 | Transmembrane protein 52 | 1 | Other mediation | 1 | 0.50 | ||||
| TMM61 | Q8N0U2 | Transmembrane protein 61 | Predicted membrane proteins | 2 | Other mediation | 1 | 0.50 | |||
| TMM65 | Q6PI78 | Transmembrane protein 65 | Disease related genesPotential drug targetsPredicted membrane proteinsTransporters | 3 | Other mediation | 1 | 0.50 | |||
| TMPSD | Q9BYE2 | Transmembrane protease serine 13 (EC 3.4.21.-) (Membrane-type mosaic serine protease) (Mosaic serine protease) | 1 | Other mediation | 1 | 0.50 | ||||
| TMTC2 | Q8N394 | Protein O-mannosyl-transferase TMTC2 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 2) (Transmembrane and tetratricopeptide repeat-containing 2) | EnzymesPredicted membrane proteins | 11 | Metabolism mediation | 1 | 0.50 | |||
| TNR11 | Q9Y6Q6 | Tumor necrosis factor receptor superfamily member 11A (Osteoclast differentiation factor receptor) (ODFR) (Receptor activator of NF-KB) (CD antigen CD265) | CD markersDisease related genesHuman disease related genesPredicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 |